Filing Details

Accession Number:
0001209191-20-059855
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-23 06:05:10
Reporting Period:
2020-11-19
Accepted Time:
2020-11-23 06:05:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1478320 Adaptive Biotechnologies Corp ADPT Biological Products, (No Disgnostic Substances) (2836) 270907024
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1780854 Sharon Benzeno C/o Adaptive Biotechnologies Corp.
Suite 200
Seattle WA 98102
Chief Business Development Off No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-19 416 $6.27 416 No 4 M Direct
Common Stock Disposition 2020-11-19 416 $48.86 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-11-19 416 $0.00 416 $6.27
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,084 2027-04-25 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020.
  2. The options vested with respect to 1/4 of such shares on April 19, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.